Method and System for Identification of Metabolites Using Mass Spectra by Moseley, Hunter N. B. et al.
University of Kentucky 
UKnowledge 
Molecular and Cellular Biochemistry Faculty 
Patents Molecular and Cellular Biochemistry 
3-31-2020 
Method and System for Identification of Metabolites Using Mass 
Spectra 
Hunter N. B. Moseley 
University of Kentucky, hunter.moseley@uky.edu 
William J. Carreer 
University of Kentucky, jim.carreer@uky.edu 
Joshua Mitchell 
University of Kentucky, jmmi243@uky.edu 
Robert M. Flight 
University of Kentucky, robert.flight@uky.edu 
Follow this and additional works at: https://uknowledge.uky.edu/biochem_patents 
 Part of the Medical Biochemistry Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Moseley, Hunter N. B.; Carreer, William J.; Mitchell, Joshua; and Flight, Robert M., "Method and System for 
Identification of Metabolites Using Mass Spectra" (2020). Molecular and Cellular Biochemistry Faculty 
Patents. 28. 
https://uknowledge.uky.edu/biochem_patents/28 
This Patent is brought to you for free and open access by the Molecular and Cellular Biochemistry at UKnowledge. 
It has been accepted for inclusion in Molecular and Cellular Biochemistry Faculty Patents by an authorized 
administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
c12) United States Patent 
Moseley et al. 
(54) METHOD AND SYSTEM FOR 
IDENTIFICATION OF METABOLITES USING 
MASS SPECTRA 
(71) Applicant: UNIVERSITY OF KENTUCKY 
RESEARCH FOUNDATION, 
Lexington, KY (US) 
(72) Inventors: Hunter N. B. Moseley, Lexington, KY 
(US); William J. Carreer, Lexington, 
KY (US); Joshua Mitchell, Lexington, 
KY (US); Robert M. Flight, Lexington, 
KY (US) 
(73) Assignee: UNIVERSITY OF KENTUCKY 
RESEARCH FOUNDATION, 
Lexington, KY (US) 
( *) Notice: Subject to any disclaimer, the term ofthis 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 297 days. 
(21) Appl. No.: 15/642,143 
(22) Filed: 
(65) 
Jul. 5, 2017 
Prior Publication Data 
US 2018/0011990 Al Jan. 11, 2018 
Related U.S. Application Data 
(60) Provisional application No. 62/358,411, filed on Jul. 
5, 2016. 






(52) U.S. Cl. 
CPC .............. GI6C 20120 (2019.02); A6IB 51055 
(2013.01); GOIN 33/5038 (2013.01); 
(Continued) 
r,- ..... ,.... ..... ,.... .................... ....,..., 
I 1111111111111111 1111111111 1111111111 lllll 111111111111111 111111111111111111 
USO 10607723B2 
(IO) Patent No.: US 10,607,723 B2 
Mar.31,2020 (45) Date of Patent: 




CPC ......... G06F 19/00; G06F 19/10; A61B 5/055; 
GOIN 33/50; GOIN 33/68; H0lJ 49/26 
(Continued) 
References Cited 
U.S. PATENT DOCUMENTS 
6,764,817 Bl 
7,402,437 B2 
7 /2004 Schneider 
7/2008 Gonzalez et al. 
(Continued) 
FOREIGN PATENT DOCUMENTS 
2008/151856 12/2006 
WO-2013/170099 Al 11/2013 
OTHER PUBLICATIONS 
Hellerstein, M. K. et al, American Journal of Physiology 1999, 276, 
Ell46-Ell 70. * 
(Continued) 
Primary Examiner - Arlen Soderquist 
(74) Attorney, Agent, or Firm - Stephen J. Weyer, Esq.; 
Mandy Wilson Decker, Esq.; Stites & Harbison, PLLC 
(57) ABSTRACT 
A method and system is provided for mass spectrometry for 
identification of a specific elemental formula for an 
unknown compound which includes but is not limited to a 
metabolite. The method includes calculating a natural abun-
dance probability (NAP) of a given isotopologue for iso-
topes of non-labelling elements of an unknown compound. 
Molecular fragments for a subset of isotopes identified using 
the NAP are created and sorted into a requisite cache data 
structure to be subsequently searched. Peaks from raw 
spectrum data from mass spectrometry for an unknown 
compound. Sample-specific peaks of the unknown com-
pound from various spectral artifacts in ultra-high resolution 
Fourier transform mass spectra are separated. A set of 
possible isotope-resolved molecular formula (IMF) are cre-
ated by iteratively searching the molecular fragment caches 
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and combining with additional isotopes and then statistically 
filtering the results based on NAP and mass-to-charge (m/2) 
matching probabilities. An unknown compound is identified 
and its corresponding elemental molecular formula (EMF) 
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METHOD AND SYSTEM FOR 
IDENTIFICATION OF METABOLITES USING 
MASS SPECTRA 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application claims benefit of U.S. Provisional Appli-
cation No. 62/358,411, filed Jul. 5, 2016, which is hereby 
incorporated by reference. 
FIELD OF THE INVENTION 
The presently-disclosed subject matter relates to methods 
and systems for identification of an unknown compound. In 
particular, the presently-disclosed subject matter relates to 
identification of an unknown compound, which includes but 
is not limited to metabolites, detected by mass spectrometry, 
including ultra-high resolution mass spectrometry. The pres-
ently-disclosed subject matter further relates to identifica-
tion of molecular formulas of detected compounds including 
metabolites. 
BACKGROUND OF THE INVENTION 
Metabolomics is a systematic detection and study of the 
metabolites (small biomolecules <2000 Dalton) present in 
samples derived from living systems. Recent advances in 
ultra-high resolution mass spectrometry enables rapid detec-
tion of tens of thousands of isotopologues (i.e. mass equiva-
lent sets of isotopomers) representing thousands of metabo-
lites. Yet, the necessity for metabolite identification, 
quantitative analysis, and interpretation, within the context 
2 
abundance probability (NAP) of a given isotopologue for the 
set of isotopes it contains or a relative NAP if the labeling 
isotopes are present; ii) algorithms to efficiently build and 
sort large (multiterabyte) caches of molecular fragments for 
5 a subset of isotopes being searched; iii) algorithms that 
characterize peaks from a raw spectrum and separate 
sample-specific peaks from various spectral artefacts seen in 
ultra-high resolution Fourier transform mass spectra; iv) 
algorithms that create sets of possible IMFs by iteratively 
10 searching the molecular fragment caches and combining 
with additional isotopes and then statistically filtering the 
results based on NAP and mass-to-charge (m/z) matching 
probabilities; and v) an algorithm that identify a metabolite 
and its corresponding EMF from statistically-significant 
15 cliques of isotopologues with compatible IMFs. FIG. lA 
(flowchart) and FIG. 1B (system schematic) show an over-
view of how these five components are used to determine 
statistically significant EMF cliques. 
Again, all five components are necessary to determine 
20 IMFs of specific isotopologues and related offset peaks via 
the identification of their associate EMF clique representing 
a specific metabolite or a set of metabolites that are struc-
tural isomers. Also, this approach is applicable to a directed 
search of known EMFs by building an isotopically-resolved 
25 cache (Component 2) for only these known EMFs. And this 
approach is applicable to the analysis of tandem mass 
spectroscopic (MSn) data, where the set of possible IMFs of 
specific fragment isotopologues are probabilistically inter-
sected with the set of possible IMFs of the parent isotopo-
30 logue. 
Component 1. 
of relevant metabolic networks, represents key barriers to 
the use of this avalanche of information-rich, phenotypic 35 
metabolomics data. In fact, over 50% of detected metabo-
lites remain unidentified in ultra-high resolution mass spec-
n 
NAP= n PEJ 
j=l tra and there is low confidence in those metabolites identi-
fied without a comparison to standards. With stable isotope-
resolved metabolomics (SIRM) experiments, comparison to 40 
millions ( or billions) of isotopically-different chemical stan-
dards is not possible. 
SUMMARY OF THE INVENTION 
The above equations describe the calculation of the natu-
ral abundance probability (NAP) for specific isotopically-
resolved molecular formulas. In the case where a specific 
isotope(s) comes from a labeling source, a relative NAP is 
45 calculated where that isotope's contribution to the element's 
probability (PE) is omitted. For isotope combinations for an 
element containing 3 or more isotopes, one of which is 
labeled, a relative NAP can be calculated using the remain-
This disclosure describes the development, prototyping, 
and implementation of a novel algorithm that detects 
metabolites at a desired statistical confidence and determines 
their specific elemental molecular formula (EMF) using 
detected sets (i.e. cliques) of related isotopologue peaks with 50 
compatible isotope-resolved molecular formulae (IMFs ). 
The methodology works on both mass spectra derived from 
non-SIRM experiments, but especially on mass spectra from 
SIRM experiments that contain metabolites labeled with 
specific stable isotopes like 13C, 15N, and 2 H from a given 
labeling source and/or from natural abundance. This 
approach has none of the limitations of current methods that 
can only detect known metabolites in a database. Thus this 
new method enables the full interpretation of untargeted 
metabolomics studies through the identification of metabo-
lites at the level of structural isomers representing the same 
EMF. 
The approach outlined in this disclosure requires five key 
components to overcome the inherent IMF combinatorial 
search problem and then identify statistically significant 
EMFs from tens of thousands of possible IMFs. The five key 
components are: i) algorithms that calculate the natural 
ing isotopes else the relative NAP is set to one. 
Component 2. 
The problem of searching for probable isotopically-re-
solved molecular formulas is a huge combinatorial problem 
that becomes intractable on even large supercomputers for 
molecular masses over 500 Daltons. In order to make this 
55 problem tractable, you must build a large multiterabyte 
sorted cache of plausible molecular formula fragments using 
the NAP from Component 1 and metabolite bonding pattern 
rules for the elements in the cache. In addition, efficient 
merge sort algorithms are required to effectively sort a list 
60 containing 1 00's of billions of elements and keep the needed 
disk space required to build the cache to roughly twice the 
size of the final sorted cache. The cache reduces the molecu-
lar formula search time by a ratio of the time to build the 
cache (typically> 1,000 CPU hours) versus the time it takes 
65 to search the cache (i.e. milliseconds or better). An example 
metabolite bonding pattern rule is the number of hydrogen 
atoms in a molecular formula is bounded by the number of 
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clique in the mass spectrum. Specific EMF cliques are 
identified by statistically evaluating the sum of complemen-
tary pair probabilities/likelihoods. Restated, a goodness-of-
fit score for a clique is created from the sum of pair 
available valence electrons. Current prototype caches take 
roughly 3 terabytes of storage; however, future caches 
would grow with available storage capacities. Efficient uti-
lization of the cache requires an in-memory binary search 
tree approximately equal to: 16*cache_size/4096 bytes. 
Component 3. 
5 probabilities/likelihoods. Statistically significant goodness-
of-fit scores are evaluated against randomly generated 
cliques derived from isotopologues of incompatible cliques 
at a certain significance level. The resulting analysis iden-
Detected peaks within spectra collected from Fourier 
transform mass spectrometers have a variety of data quality 
issues including m/z peak shifting (FIGS. 2A and 2B), 
inconsistency in peak heights and areas (FIG. 3), and the 10 
presence of artefactual peaks. These data quality issues arise 
from: i) limitations in digital resolution (FIG. 4); ii) prob-
lems with scan-level consistency (FIG. 5); iii) Fourier trans-
form-based artefacts (FIG. 6), and iv) the presence of 
contaminants. However, standard peak picking methods that 15 
average across scans create huge data quality issues. There-
fore, an integrated procedure using a combination of new 
scan-level peak characterization methods along with artefact 
peak detection methods are required to derive high quality 
peak characteristics associated with specific isotopologues. 20 
Peak characterization at the scan-level is implemented by 
removing noise peaks per scan, corresponding peaks across 
scans, and performing normalization of peak heights/areas 
across scans. The resulting correspondence peaks are used to 
derive high quality peak heights and areas (FIGS. 7 and 8) 25 
while removing many of the high peak density artefacts 
present but inconsistent at the scan-level. Separate high peak 
density analyses and contaminant detection will remove or 
mark the remaining artefactual peaks. A list of contaminant 
molecules can be based on expected contaminate molecules 30 
from the plastics and solvents used in sample preparation 
including polymers like polyethylene glycol (PEG) and 
polymer detergents like triton X-100 or derived from quality 
control samples directly. A difference matrix generated from 
this list of expected molecules is compared to the difference 35 
matrix generated from the peak list derived from a mass 
spectrum. Rows between the two matrices with a statisti-
cally significant number of differences that match are used 
to assign expected contaminant peaks and derive offsets 
present in the spectrum. 
Component 4. 
40 
Each isotopologue is identified by a peak with a specific 
mass to charge ratio (m/z ratio) position in the ID mass 
spectrum. The peak also has an intensity related to the 
number of ions physically detected in the mass spectrometer. 45 
For each characterized isotopologue peak, a set of possible 
isotopically-resolved molecular formulas (IMFs) are calcu-
lated within a specified accuracy tolerance using Component 
2 to build specific isotopically-resolved molecular formulas 
that are then filtered against: i) the NAP from Component 1; 50 
ii) a statistical measure of how well the molecular formula 
matches the m/z ratio (m/z matching probability); and iii) 
metabolite bonding pattern rules. 
Component 5. 
A clique of compatible isotopologue peaks associated 55 
with a specific EMF is identified via a nonempty intersection 
between their sets of possible EMFs identify from their 
possible IMFs. In addition, each complementary pair of 
isotopologues (i.e. has equal numbers of labeling isotopes) 
from a specific EMF clique is statistically evaluated using 60 
both m/z matching probabilities from Component 3 and a 
log ratio of isotopologue intensities statistically compared to 
the log ratio of each IMF NAP from Component 1 (log-ratio 
match probability). The isotopologue intensities used in the 
ratios are derived from associated characterized peaks. Each 65 
complementary pair represents a statistically evaluated piece 
of evidence supporting the existence of the associate EMF 
tifies EMF cliques of isotopologue peaks associated with 
one or more structural isomers at a specified level of 
statistical significance. 
Table 1 (below) shows a proof of concept application of 
implementation of Components 1-5 to a peak list derived 
from a Thermo Orbitrap Fusion Tribrid FTMS spectrum of 
a biological sample that had been treated with the ECF 
(2Cl-CO2Et) chemoselection agent. Twenty-seven out of 
the 31 verified EMF cliques were detected and assigned by 
the prototype tool, representing an 87% correctly assigned 
rate. Peaks from one clique were misassigned, representing 
a 3.6% false discovery rate (FDR). FIGS. 8, 9A and 9B 
demonstrate the quality of the fit between observed and 
theoretical relative isotopologue intensities for a detected 
EMF clique and across a targeted set of verified cliques. The 
peak characterization in Component 3has greatly reduced 
known FTMS ion suppression effects as illustrated by the 
slope between normalized NAP values and relative intensi-
ties in FIG. 9A. These results clearly show the utility of this 
approach to derive validated EMFs from FTMS peak lists. 
The current prototype is able to efficiently search a roughly 
4.8 quintillion (4.8xl018) IMF space for each peak's m/z, 
based on molecular masses <=2000 daltons, but larger IMF 
spaces are searchable. 
TABLE 1 
Validated EMFs from Biological Sample Detected Using 
a Prototype Implementation 
EMF Assignment Clique Size 
Cl0ElHl 7N1Na1O4 Assigned 4 
Cl0ElHl 7N1Na1O6 Assigned 3 
C10E1H18N2Na1O5 Assigned 4 
C10E1H19N1Na1O4 Assigned 4 
C11E1H19N1Na1O6 Assigned 5 
C11E1H21N1Na1O4 Assigned 5 
C11E1H21N3Na1O5 Assigned 5 
C11E1H23N4O4 Assigned 2 
C12E1Hl 7N3Na1O6 Assigned 2 
C12E1H20N3O4 Assigned 5 
C12E1H21N1Na1O6 Assigned 3 
C12E1H22N2Na1O6 Assigned 2 
C13E1H23N1Na1O6 Assigned 4 
C14E1H19N1Na1O4 Assigned 5 
C14E1H21N3Na1O6 Assigned 3 
C14E1H22N3O6 Assigned 3 
C15E1H25N4O5 Assigned 2 
C16E1H20N2Na1O4 Assigned 6 
Cl 7E1H30N2Na1O8Sl Assigned 8 
C7E1H13N1Na104 Assigned 3 
C8E1H15N1Na104 Assigned 5 
C8E1H15N1Na105 Assigned 3 
C9E1H15N1Na106 Assigned 3 
C9E1Hl 7N1Nal 04 Assigned 5 
C9E1Hl 7N1Nal 05 Assigned 3 
C10E1H19N1Na1O4Sl Assigned 4 
C 18E1H29N407 Alternative 2 
Assignment 
C14E1H24N2Na1O8S2 Not Assigned NIA 
C14E1H26N2Na1O6 Not Assigned NIA 
C15E1H26N2Na1O8Sl Not Assigned NIA 
C16E1H28N2Na1O8S2 Not Assigned NIA 
US 10,607,723 B2 
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Furthermore, this methodology can be extended to sets of 
detected EMF cliques (super-cliques) representing different 
chemical derivitizations of a specific metabolite. Differences 
in the EMFs reflect additions of known chemoselective tags 
and/or adducts to specific metabolites represented by the 5 
EMF of the base clique. A goodness-of-fit score can be 
calculated for super-cliques of known derivitizations. Fur-
thermore, a comparison of the matrix of log intensity ratios 
for specific cliques can be used to identify super-cliques of 
unknown derivitizations. 10 
The present invention, in one form thereof is directed to 
a method for mass spectrometry data analysis for identifi-
cation of a specific elemental molecular formula (EMF) for 
6 
FIG. lA is a flowchart showing a metabolite identification 
process using ultra-high resolution mass spectrometry in 
accordance with the present invention. 
FIG. lB is a schematic showing how five components of 
the identification process interact with one another to iden-
tify an unknown compound in accordance with the present 
invention. 
FIG. lC is a schematic of a system for metabolite iden-
tification in accordance with the present invention. 
FIGS. 2A and 2B are two respective graphs showing 
spectra collected from Founer transform mass spectrometers 
showing peak m/z offset patterns detected, where FIG. 2A 
shows Thermo Orbitrap Fusion Tribrid FTMS spectrum 
15 
mainly due to digital resolution and scan-level consistency 
issues and FIG. 2B shows Bruker SolariX XR ICR FTMS 
an unknown compound. The method includes calculating a 
natural abundance probability (NAP) of a given isotopo-
logue for isotopes of non-labeling elements of an unknown 
compound and creating and sorting caches of molecular 
fragments for a subset of isotopes identified using the NAP, 
into a requisite cache data structure, to be searched. Peaks 20 
from raw spectrum from mass spectrometry for an unknown 
compound are characterized and sample-specific peaks are 
separated from various spectral artefacts seen in ultra-high 
resolution Fourier transform mass spectra. Sets of possible 
isotope-resolved molecular formulae (IMFs) are created by 25 
iteratively searching the molecular fragment caches and 
combining with additional isotopes and then statistically 
filtering the results based on NAP and mass-to-charge (m/z) 
matching probabilities. An unknown compound is identified 
and its corresponding EMF determined from statistically- 30 
significant cliques of isotopologues with compatible IMFs. 
The present invention is another form thereof is directed 
to a system of mass spectrometry data analysis for identi-
fication of a specific elemental molecular formula (EMF) for 
35 
an unknown compound. The system includes computer 
memory adapted to store mass spectrometry data for an 
unknown compound and a computer processor adapted for 
performing analytics on mass spectrometry data from mass 
spectrometry for the unknown compound. The processor 40 
calculates a natural abundance probability (NAP) of a given 
isotopologue for isotopes of non-labeling elements of an 
unknown compound. Further, the processor creates and sorts 
caches of molecular fragments for a subset of isotopes 
identified using the NAP, into a requisite cache data struc- 45 
ture, to be searched. Next, peaks from raw spectrum are 
characterized and sample-specific peaks are separated from 
various spectral artefacts and noise seen in ultra-high reso-
lution Fourier transform mass spectra. Further, the processor 
creates sets of possible isotope-resolved molecular formulae 50 
(IMF) by iteratively searching the molecular fragment 
caches and combining with additional isotopes and then 
statistically filtering the results based on NAP and mass-to-
charge (m/z) matching probabilities. Finally, the processor 
identifies an unknown compound and its corresponding 55 
EMF from statistically-significant cliques of isotopologues 
with compatible IMFs. 
spectrum mainly due to ringing artefacts derived from 
truncation issues in the Fourier transformation. 
FIG. 3 includes graphs showing Relative Standard Devia-
tion of peak heights and areas across raw scans in a Thermo 
Orbitrap Fusion Tribrid FTMS spectrum. 
FIGS. 4A-4C are graphs demonstrating limitations in 
digital resolution and scan-level inconsistencies leading to 
peak m/z offsets in a Thermo Orbitrap Fusion Tribrid FTMS 
spectrum in which FIG. 4A shows average spectrum for a 
peak across all transients, FIG. 4B is a set of 11 transient 
scans, and FIG. 4C shows highest intensity point for each 
scan. 
FIG. 5 shows scan-level inconsistencies in signal and 
noise for a Thermo Orbitrap Fusion Tribrid FTMS spectrum. 
FIGS. 6A-C show three types of high peak density 
FTMS-based spectral artefacts: FIG. 6A fuzzy sites, FIG. 6B 
ringing, and FIG. 6C partial ringing. 
FIG. 7 illustrates the improved relative Standard Devia-
tion of peak heights and areas across normalized scans in a 
Thermo Orbitrap Fusion Tribrid FTMS spectrum. 
FIG. 8 shows a comparison of observed vs NAP theoreti-
cal relative peak heights for a clique of characterized iso-
topologue peaks. 
FIGS. 9A and 9B show that minimal ion intensity effects 
are observed after peak characterization, in which FIG. 9A 
shows regression of normalized NAP versus relative inten-
sity, and FIG. 9B is a histogram oflog NAP ratios minus log 
intensity ratios. 
FIG. 10 is a diagram illustrating class relationships and 
modularization of parallelized natural abundance (NA) cor-
rection algorithm. 
FIG. 11 is a graph showing improvement in multiprocess-
ing NA correction running time with increasing numbers of 
processors used. 
FIG. 12 depicts pathways from [U- 13C]-glucose to the 
four biochemical subunits ofUDPGlcNAc. Glucose moiety 
is incorporated directly. Acetyl moiety is incorporated via 
glycolysis. Ribose moiety is incorporated via the pentose 
phosphate pathway. Uracil moiety derives from acetyl-CoA 
via the citric acid cycle to form aspartate where it is 
combined with carbamoyl phosphate. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The novel features of the invention are set forth with 
particularity in the appended claims. A better understanding 
FIG. 13A lists chemical substructure model representing 
the possible number of 13C incorporation from 13CcGlc 
60 tracer into UDP-GlcNAc, accounting for the observed FT-
ICR-MS isotopologue peaks. 
of the features and advantages of the present invention will 
be obtained by reference to the following detailed descrip-
tion that sets forth illustrative embodiments, in which the 65 
principles of the invention are used, and the accompanying 
drawings of which: 
FIG. 13B shows the structure ofUDP-GlcNAc annotated 
by its chemical substructures and their biosynthetic path-
ways from 13CcGlc. NAc-Glucose utilizes Gin as the nitro-
gen donor. 
FIG. 13C is a graph showing fit of optimized chemical 
substructure model parameters to F-ICR-MS isotopologue 
US 10,607,723 B2 
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data of UDP-GLcNAc extracted from human cell culture 
after 48 hr of growth in 13C6 -Glc. 
FIG. 14 is a graph illustrating a deconvoluted time course 
of FT-ICR-MS isotopologue peaks of UDP-GlcNAc from 
human cell culture extract. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this document. 
Modifications to embodiments described in this document, 
and other embodiments, will be evident to those of ordinary 
skill in the art after a study of the information provided in 
this document. The information provided in this document, 
and particularly the specific details of the described exem-
plary embodiments, is provided primarily for clearness of 
understanding and no unnecessary limitations are to be 
understood therefrom. In case of conflict, the specification of 
this document, including definitions, will control. 
8 
While global metabolomics, including the quantification 
of a large number of metabolites in tissue or biofluids, can 
identify disease states or response to therapeutics by refer-
ence to the normal condition, determining specific mecha-
5 nisms, such as detecting which pathways are impacted in 
particular cell types within a tissue by measuring metabolic 
fluxes, requires additional information. Indeed, many 
metabolites are present in different amounts in different cell 
types or within compartments of cells, as well as participat-
10 ing in several pathways simultaneously. To identify precur-
sor-product relationships, it is necessary to distinguish dif-
ferent sources of carbon, nitrogen etc. which necessitates 
some means of "labeling" individual atoms so that their fate 
can be traced through metabolic pathways. Traditionally this 
15 was achieved using radioisotopes. However, stable isotopes 
have several advantages, including being wholly biocom-
patible, and also individual atoms within a metabolite are 
easily distinguishable by NMR and mass spectrometry. 
Stable Isotope Resolved Metabolomics (SIRM) is an 
20 approach that has been developed, which combines the 
power of global (untargeted) metabolic profiling with atom-
resolved tracking of metabolites during metabolic transfor-
mations within cells, tissue or whole organisms. The cell 
culture, tissue, or organism is provided with a source 
Unless defined otherwise, all technical and scientific 
terms used herein have the same meaning as is commonly 
understood by one of skill in the art to which the invention(s) 
belong. All patents, patent applications, published applica-
tions and publications, GenBank sequences, databases, web-
sites and other published materials referred to throughout the 
entire disclosure herein, unless noted otherwise, are incor-
porated by reference in their entirety. In the event that there 
are a plurality of definitions for terms herein, those in this 
section prevail. Where reference is made to a URL or other 30 
such identifier or address, it understood that such identifiers 
can change and particular information on the internet can 
come and go, but equivalent information can be found by 
searching the internet. Reference thereto evidences the 
availability and public dissemination of such information. 
25 metabolite that is enriched at any or all of the atoms with a 
stable isotope (like 13C or 15N with natural abundances 1.1 % 
and 0.37%, respectively), and the products are analyzed by 
NMR and MS at different times after treatment. Such 
products will include isotopomers, which are isomers having 
the same isotopes, but differing in the location of the 
isotopes (e.g., 13CH3CH2 CH2 CH3 vs. CH3 CH2
13CH2 CH3 ), 
and isotopologues, which are sets of isotopomers with the 
same mass. With SIRM data in hand, specific isotopomer 
and isotopologue distributions in the various product 
35 metabolites can be determined, along with the total amounts 
of the metabolites, which together provide detailed infor-
mation about the relative importance of intersecting and 
parallel pathways. For example, lactate can be produced 
directly from glucose by lactic fermentation, as well as by 
Although any methods, devices, and materials similar or 
equivalent to those described herein can be used in the 
practice or testing of the presently-disclosed subject matter, 
representative methods, devices, and materials are now 
described. 
Metabolomics can be described as the study of collections 
of metabolites, both intermediate and end products of cel-
lular processes. Living cells are maintained under non-
equilibrium conditions, which requires constant input of 
energy. The cells must also maintain their infrastructure, and 
perform tissue-specific tasks, all of which need energy and 
raw material. Metabolism is the set of processes that convert 
exogenous compounds to metabolic energy, which drives 
biochemical reactions within the cell, maintains homeosta-
sis, provides the means to do work (e.g. contraction, move-
ment, action potentials, secretion and so forth), for cellular 
repair, and to divide. Metabolism responds to exogenous 
signals as represented by diet and pollutants for example, 
and local environments (microenvironment) as represented 
by the conditions prevailing outside cells in tissues. As such, 
metabolism is a sensitive indicator of pathology, and the 
ability to measure global metabolism in quantitative detail is 
of fundamental importance in all aspects of biology. Prac-
tical examples include prediction and identification of dis-
ease state and prediction of response to therapeutics. 
40 glutaminolysis; the relative contributions from these inde-
pendent pathways is readily determined from the isotope 
distributions in the lactate using either 13C-enriched glucose 
or glutamine as labeled sources. At the same time such 
labeling schemes provide simultaneous information about 
45 the flow of carbon through the pentose phosphate pathway, 
glycolysis, hexosamine pathway, the Krebs cycle and lipid 
biosynthesis among others. 
Recent advances in metabolomics technologies, such as 
SIRM, which combine the complementary isotope-sensitive 
50 techniques of MS and NMR, enable rapid detection of tens 
of thousands of isotopologues and isotopomers representing 
thousands of metabolites; however, the necessity for 
metabolite identification, quantitative analysis, and interpre-
tation, within the context of relevant metabolic networks, 
55 represents key barriers to the use of this avalanche of 
information-rich phenotypic data. In fact, over 50% of 
detected metabolites represented by cliques of detected 
spectral features remain unidentified in ultra-high resolution 
mass spectra. Therefore, the present inventors have devel-
60 oped a system and method that determines the isotope-
resolved molecular formula for metabolites detected via sets Metabolomics tools provides the technical means to carry 
out global analyses of metabolism, by identifying and quan-
tifying a large fraction of all of the metabolites present in a 
cell, and how they change in response to perturbations 
within relevant metabolic networks. Metabolomics therefore 65 
requires high-end analytical instrumentation, including mass 
spectrometry (MS). 
of related isotopologues from mass spectra of samples that 
have been labeled with specific stable isotopes like 13C, 15N, 
and 2 H from a given labeling source and/or from natural 
abundance. 
The presently-disclosed subject matter includes methods 
and systems that allow for identification of metabolites that 
US 10,607,723 B2 
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are detected using MS. Methods and systems of the pres-
ently-disclosed subject matter can involve processing and/or 
obtaining MS data. In some embodiments of the presently 
disclosed subject matter, the metabolites are identified has 
having a particular element-specific molecular formulae 5 
(EMFs). In some embodiments, the metabolites are identi-
fied has having a particular isotope-specific molecular for-
mulae (IMFs). 
Referring now to the present method with specific refer-
ence to the drawings, and in particular FIGS. lA-lC. FIG. 10 
lA is a flowchart that shows an overall high-level method in 
accordance with the present invention for identifying an 
unknown compound and FIG. lC is a high-level schematic 
of a system 100 that can implement method 10. Method 10 
incorporates the five (5) main components of the present 15 
method for identifying an unknown compound including 
metabolites. Accordingly, FIG. 1B is a high-level schematic 
showing how the five main components of method 10 
interact to identify an unknown compound. The system 100 
comprises a mass spectrometer (MS) 110 associated with a 20 
computer 130 for identifying metabolites in a sample (i.e. 
Metabolites 120). Mass Spectrometer 110 generates spectral 
data from unknown metabolites 120. The computer 130 
analyzes the spectral data using a processor 132, processor 
memory 134 and data storage 136. While FIG. lC shows 25 
computer 130 as containing a i) processor 132, ii) processor 
memory 134 and iii) data storage 136, each of these three 
components can be distributed across a computer network, 
processor 132 may comprise multiple processors connected 
together, and/or computer memory 134 and data storage 136 30 
may be separate components ( e.g. peripherals) operatively 
associated with a computer/computer processor. 
A first step in method 10 is molecular fragment cache 
building (step 20). This includes creating molecular frag-
ments for a given set of isotopes within a mass range (step 35 
21). Next a partial NAP is calculated of reach molecular 
fragment using processor 132 (step 22). Further, based on 
this calculation, probable molecular fragments are kept for 
further analysis (step 23). Molecular fragments are sorted by 
mass (step 24). Finally with regard to the molecular frag- 40 
ment cache building (step 20), a binary-like search tree is 
generated (step 25) and stored in computer storage 136. 
Accordingly, step 20 implements Component 1 and Com-
ponent 2 of the present method for identifying an unknown 
compound as shown in FIG. 1B. The result of all parts of 45 
step 20 is a multi-terabyte molecular fragment cache 30 that 
is created in computer storage 136 (FIG. lC). 
10 
organized into possible EMFs (step 60). EMFs are selected 
by processor 132 that exceed a predetermined or given 
statistical significance (step 70). Based on this, a list of 
detected EMF caches are identified (step 80). This list of 
detected EMF caches allows one to identify the specific 
actual elemental molecular formula for the unknown com-
pound such as a metabolite. Accordingly, the present method 
can be used to identify compounds such as the elemental 
molecular formula for an unknown metabolite. 
In some embodiments, methods of the presently-disclosed 
subject matter involve assembling a large sorted cache of 
plausible molecular formula fragments. Such assembly can 
involve use of metabolite bonding pattern rules for elements 
in the cache. For example, the number of hydrogens is 
bounded by the number of carbons and nitrogens. Such 
assembly can also involve calculating a natural abundance 
probability (NAP) of isotopes of non-labeling elements 
(e.g., 13C has a natural abundance of 1.1%). In some 
embodiments, the NAP can be calculated using the follow-
ing formula: xxx 
n 
NAP= n PEJ 
j=l 
This formula can be used to calculate the NAP for specific 
isotopically-resolved molecular formulas. In the case where 
a specific isotope(s) comes from a labeling source, a relative 
NAP is calculated where that isotope's contribution to the 
element's probability (PE) is omitted. For isotope combina-
tions for elements containing 3 or more isotopes, one of 
which is labeled, a relative NAP can be calculated using the 
remaining isotopes else the relative NAP is set to one. 
The set of isotopes excluded from the NAP calculation 
depends on experimental conditions ( e.g., 13C can be used as 
a label/tag, but also has a natural abundance of 1.1 % and will 
be present even when not used as a label/tag). 
In some embodiments, methods of the presently-disclosed 
subject matter involve calculating a set of possible isotopi-
cally-resolved molecular formulae for each detected isoto-
pologue, within a specified accuracy tolerance. Such isoto-
pologues can be detected, for example, by a particular m/z 
ratio peak by MS. Such calculation can involve assembling 
specific isotopically-resolved molecular formulae, and fil-
tering such formulae, for example, using calculated NAP, 
calculating m/z matching probability, a statistical measure of 
how well the molecular formula matches the m/z ratio, and 
using metabolite bonding pattern rules. 
In some embodiments, methods of the presently-disclosed 
subject matter involve identifying a metabolite isotopo-
A list of known and/or possible contaminant ions (step 31) 
along with the raw FTMS spectrum (step 32) are converted 
and analyzed in step 40 to filter out real spectral peaks from 50 
analytical artefacts, chemical artefacts, and noise. The 
resulting real spectral peaks are characterized with respect to 
peak m/z, height, and normalized area across raw FTMS 
scans. These steps correspond to Component 3 as shown in 
FIG. 18. 55 !ague-offset clique, which is a clique of isotopologue and 
offset peaks associated with a specific elemental molecular 
formula. Such identification can involve identifying com-
patible isotopically-resolved molecular formulae for pairs of 
isotopologues, by comparing their sets of isotopically-re-
As one of ordinary skill in the art will appreciate, mass 
spectrum data may include artifacts such as contaminate 
ions. Accordingly, the present method 10 identifies likely 
contaminate ions as will be discussed below in further detail 
with regard to contaminate ion identification. Using raw 
Fourier transform mass spectrometry (FTMS) and a likely 
list of contaminate ions, peaks are characterized and artifact 
peaks removed (FIG. lA, step 40 and FIG. 1B, Component 
4) using the multi-terabyte molecular fragment cache 30 in 
computer storage 136. A search of possible IMFs for each 
non-artifact peak is conducted using processor 132 and 
computer memory 134 (step 50). Subsequently, IMFs are 
60 solved molecular formulae and identifying an intersection 
between the sets. Each intersecting pair of complementary 
isotopically-resolved molecular formulae that correspond to 
the same elemental molecular formula and have equal 
numbers of labeling isotopes are statistically evaluated. 
65 Such evaluation can make use of both m/z matching prob-
abilities and calculation of a log-ratio match probability, 
which is a log ratio of isotopologue peak intensities statis-
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tically compared to the log ratio of each isotopically-
resolved molecular formula NAP. Each compatible inter-
secting pair of isotopically-resolved molecular formulae 
represents evidence for specific elemental molecular formu-
las in a mass spectrum. Specific elemental molecular for- 5 
mulae are identified by statistically evaluating the sum of 
compatible intersecting pairs of isotopically-resolved 
molecular formulas that support the same elemental molecu-
lar formula. 
bination of bioinformatic, biostatistical, and systems bio-
chemical tools for the analysis of large metabolomics 
datasets. This integrated set of analyses will have broad 
application from the discovery of specific metabolic pheno-
types representing biological states of interest to a mecha-
nism-based understanding of a wide range of specific bio-
logical processes ( cell growth, apoptosis, differentiation, 
nutrient specialization, symbiosis, etc.) with particular meta-
bolic phenotypes. 
In some embodiments, methods of the presently-disclosed 
subject matter involve identifying super cliques, with inter-
10 
clique differences in elemental and isotope-specific molecu-
Example 1. Develop tools for raw data analysis, error 
analysis, and quality control of SIRM data. The present 
inventors contemplate standardized procedures and tools for 
analyzing MS data that include peak assigmnent, metabolite 
identification, quantification, error analysis, and quality con-
trol. These tools will automate the detection and assignment 
of isotopologues from ultra-high resolution/accurate MS 
lar formulae, in the mass spectrum. Such identification can 
involve comparing a pair of detected metabolite isotopo-
logue-offset cliques using a matrix of log intensity ratios. 
Such differences in elemental and isotope-specific molecular 15 
formulae can reflect additions of known tags and/or adducts 
histograms. Emphasis is put on the development of methods 
for detecting and facilitating assignment of unidentified 
metabolites, as well as error analysis of isotopologue inten-
to specific metabolites represented by the elemental molecu-
lar formula of the base clique. 
Following long-standing patent law convention, the terms 
"a", "an", and "the" refer to "one or more" when used in this 
application, including the claims. Thus, for example, refer-
ence to "a cell" includes a plurality of such cells, and so 
forth. 
Unless otherwise indicated, all numbers expressing quan-
tities of ingredients, properties such as reaction conditions, 
and so forth used in the specification and claims are to be 
understood as being modified in all instances by the term 
"about". Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this specification and 
claims are approximations that can vary depending upon the 
desired properties sought to be obtained by the presently-
disclosed subject matter. 
As used herein, the term "about," when referring to a 
value or to an amount of mass, weight, time, volume, 
concentration or percentage is meant to encompass varia-
tions of in some embodiments ±20%, in some embodiments 
±10%, in some embodiments ±5%, in some embodiments 
±1%, in some embodiments ±0.5%, and in some embodi-
ments ±0.1 % from the specified amount, as such variations 
are appropriate to perform the disclosed method. 
As used herein, ranges can be expressed as from "about" 
one particular value, and/or to "about" another particular 
value. It is also understood that there are a number of values 
disclosed herein, and that each value is also herein disclosed 
as "about" that particular value in addition to the value itself. 
For example, if the value "10" is disclosed, then "about 10" 
is also disclosed. It is also understood that each unit between 
two particular units are also disclosed. For example, if 10 
and 15 are disclosed, then 11, 12, 13, and 14 are also 
disclosed. 
As used herein, "optional" or "optionally" means that the 
subsequently described event or circumstance does or does 
not occur and that the description includes instances where 
said event or circumstance occurs and instances where it 
does not. For example, an optionally variant portion means 
that the portion is variant or non-variant. 
The presently-disclosed subject matter is further illus-
trated by the following specific but non-limiting examples. 
The following examples may include compilations of data 
that are representative of data gathered at various times 
during the course of development and experimentation 
related to the present invention. 
EXAMPLES 
These Examples describe studies that have been con-
ducted and/or are contemplated, which provide for a com-
20 sities. The new methods are truly innovative since they 
utilize the combined advantages of stable isotope labeling, 
new chemoselective probes being developed by collabora-
tors, ultra-high resolution/accurate MS, allowing better inte-
gration with other sources of data, especially NMR isoto-
25 pomer-specific data. The present inventors are also 
leveraging metabolite and spectral information in public 
databases to facilitate assignment via functional group and 
substructure searches. 
Develop clique-based methods for identifying FT-MS-
30 observed metabolite isotopologues. CREAM has imple-
mented, in the program PREMISE [5], an algorithm for 
automated assigmnent of compounds utilizing the ultra-high 
resolution and mass accuracy capability of the FT-MS and 
has created a database of known metabolites with their exact 
35 masses calculated to 6 decimal places (accuracy and routine 
resolution of m/Am=400,000 @ 400 m/z). This approach, 
based on a single monoisotopic peak from FT-MS data, is 
limited both by the spectral signal-to-noise ratio and by the 
reliance on a database of known metabolites. A more robust 
40 approach is to use a clique of related isotopologue peaks 
( e.g. Mo to Ml 7 of UDP-GlcNAc) to detect metabolites. 
This approach greatly reduces the false positive rates with-
out using high signal-to-noise cutoffs, as the chance of 
multiple noise peaks being correlated in an isotopologue-
45 offset clique becomes infinitesimally small with increasing 
clique size. Also, the detection of a self-consistent clique 
reduces the need for a metabolite database in the initial 
detection. Furthermore, detecting all metabolite cliques 
from an FT-MS spectrum is computationally very similar to 
50 the classical problem of listing all maximal cliques in a 
graph. 
However, many algorithms that solve this problem require 
exponential computational time for their worst-case execu-
tion [11, 12]. To address these computational issues, the 
55 present inventors have designed an algorithm that makes the 
graph representation very sparse, allowing the use of opti-
mal "maximal clique" methods that sidestep the computa-
tionally challenging issues inherent in classic maximal 
clique detection algorithms [11, 13]. Many of the computa-
60 tionally expensive steps of the algorithm are easily paral-
lelizable, allowing full use of newer high-multicore (> 100 
cores) computer systems. The algorithm exploits the ultra-
high mass accuracy (routinely 5_1 ppm) and resolution 
(400,000 m/Am) of the FT-MS [14] that can distinguish 
65 mass differences between isotopologues with the same 
nominal mass but differing isotope counts. At this resolution, 
a unique or near-unique isotope-specific molecular formula 
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( e.g. 13C5 
12C1
1H12
160 6 for the MS 
13C isotopologue of 
glucose) can be directly calculated from the mass measured 
when limited to expected elements in metabolites. In the 
algorithm, the list of possible isotope-resolved molecular 
formulae is reduced to the list of elemental (non-isotope 5 
resolved) molecular formulae. Each pair of peaks within a 
sliding window of n Da of each other is then compared to see 
14 
in rare cases that a metabolite is very similar to a common 
cofactor or coenzyme like ATP. Therefore, a simple greedy 
node inclusion algorithm should suffice to identify hot spots. 
More sophisticated clustering methods will be investigated 
if needed. Ranking of hot spots will be based on a scoring 
method like the summation of node similarity multiplied by 
the highest similarity score in the hot spot. The centroid node 
and size of the hot spot may be additional useful features to 
calculate. Furthermore, this general methodology should be 
if their lists of elemental molecular formulae intersect. In 
this case, n is limited by the number of non-labeling isotopes 
of a particular labeling element present in the isotope-
specific molecular formula. The intersection test creates a 
very sparse graph. 
Detected metabolite isotopologue-offset cliques represent 
10 amenable to correlated cliques of unidentified or partially 
identified metabolites and not just a single unidentified 
metabolite. Correlated cliques of metabolites will be derived 
from covariance analyses across a time series of MS experi-
a group of isotopologues due to natural abundance isotopic 
distribution and/or enrichment from metabolic tracers. 15 
Quantitative analyses of isotopic enrichment require correc-
tion for the natural abundance of the isotopes ( e.g. 1.11 % for 
13C) before application in the reconstruction of relevant 
metabolic networks (cf. 1.13.4). The present inventors have 
designed, implemented, and parallelized algorithms based 20 
on analytical solutions that correct for the effects of isotopic 
natural abundance [3, 15] and will apply them as a final 
quality control assessment for detecting metabolite isotopo-
logue-offset cliques (cf. 1.13.2.6). 
Pairwise comparisons of detected metabolite isotopo- 25 
!ague-offset cliques will be used to identify super-cliques 
across multiple related FT-MS histograms (e.g. ±different 
chemoselective (CS) tags, ±CS isotope encoding, ±adducts, 
or ±labeled tracers), with inter-clique differences in both 
elemental (e.g. C6H1206) and isotope-specific molecular 30 
formulae. These differences reflect additions of known CS 
ments (cf. 1.13.3.2). 
However, there is a general assumption made by the 
above approach: unidentified metabolites are structurally 
similar to metabolites in known metabolic networks. This 
may not be true in some instances. An alternative approach 
is to take a correlated clique of unidentified metabolites and 
i) identify exact matches in ChemSpider for each unidenti-
fied; ii) structurally compare these exact matches between 
the unidentified; and iii) find the most common substructure 
that best spans the clique of unidentified metabolites. This 
refinement into a common substructure may improve map-
ping onto metabolic networks, especially when combined 
with additional correlation data. At the very least, this 
approach provides hypotheses of the chemical structures or 
substructures of the unidentified. Finally, open source tools 
like Cytoscape [32, 33] will be used to generate graphics that 
visualize the results from these approaches. Cytoscape is a 
general tool for visualizing networks and other graphs and is 
an excellent choice for visualizing hot spots of similarity 
within metabolic networks. In addition, common substruc-
ture similarity across a clique of metabolites can be repre-
tags, adducts, or labeled atoms to specific metabolites rep-
resented by the monoisotopic mass or base clique. Reducing 
computation to pairwise clique comparison of elemental and 
isotope-specific molecular formulae is both very efficient 
and easily parallelizable. Thus, super-clique detection will 
identify a list of functional groups or enriched isotopologues 
associated with each base clique. 
35 sented as a graph using this tool. 
Develop methods to deal with unidentified metabolites. 
Develop dataset-based and clique-based error analyses for 
quality control and evaluation of error propagation. The 
purpose of the above described methods is to reduce raw 
spectroscopic data in fully and partially identified lists of 
There are two kinds of unidentified metabolites in these 
datasets. The first is an assigned metabolite that has not been 
placed into known metabolic networks. The second kind is 
40 metabolites, with their isotopomer/isotopologue intensity 
distributions quantified, especially across a series of related 
spectra and histograms. Since FT-MS histograms typically 
take only 5 minutes to collect for a dataset containing tens 
of thousands of isotopologue peaks, it is relatively straight-
a detected compound where only its molecular formula and 
certain chemoselected functional groups have been 
assigned. To address both kinds of unidentified or partially 
assigned metabolites which make up a majority of current 
SIRM and other metabolomics datasets, the present inven-
tors contemplate the development of methods that map 
structurally similar compounds onto known metabolic net-
works, starting with versions available from KEGG Pathway 50 
[31], to determine hot spots of similarity (clusters) and 
calculate a probability or likelihood of placement. Metabolic 
network correlations between similar compounds represent 
hypotheses for where newly discovered metabolites may fit 
within metabolic networks of interest. In this regard, tools 55 
have been implemented that download the metabolic net-
works in KEGG Pathway into a local MySQL database 
which will be converted into a SQLite database. This 
mapping of compounds can be done for similar matches 
from HMDB and KEGG Compound or exact matches from 60 
ChemSpider. 
45 forward to measure and calculate both absolute and relative 
This mapping onto metabolic networks creates an addi-
tional filter on ChemSpider results that removes organic 
compounds with no significant similarity score to com-
pounds in the metabolic networks and thus are not expected 65 
to exist in general cellular metabolism. Also, mappings will 
be very sparse with respect to the metabolic network, except 
peak intensity variance across analytical replicates. From a 
quality control perspective, an abnormally high analytical 
replicate variance can indicate problems with the analytical 
platform or sampling handling. Both possibilities should be 
tested, especially when low signal-to-noise ratios are 
detected. After accounting for analytical variance, the 
remaining variance across biological replicates is often 
interpreted as being of biological origin, especially when 
mixed model methods are utilized [34]. 
However, thanks to the presence of isotope labeling due 
to natural abundance (NA), correction of natural abundance 
can also be used to calculate error at the level of a specific 
detected metabolite isotopologue-offset clique. These 13C 
and 15N natural abundance correction algorithms have been 
implemented based on the present inventors' derived ana-
lytical solution [3-5]. From rigorous tests on simulated 
datasets, these iterative correction algorithms propagate only 
half of the error expected from the non-iterative analytical 
solution. Moreover, with reference to FIGS. 10 and 11, due 
to the excellent parallelized design and optimization of these 
algorithms, NA correction in a typical isotopologue dataset 
(50000 peaks organized into 9066 metabolite isotopologue-
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offset cliques) dropped from over 600 seconds for a single 
core to less than 50 seconds with multiprocessing for 12 
cores on a Linux machine with dual Intel Xeon Processors 
X5650 (each processor has 6 cores). Because of this paral-
lelized improvement in running time, a clear and computa-
tionally practical path is seen for estimating various types of 
systematic error via simulation for each analytical replicate 
at the level of each detected and identified isotopologue. 
This is done by a comparison of varied amounts of simulated 
systematic and nonsystematic error between metabolite iso-
topologue-offset cliques within a single analytical replicate. 
When combined with an analysis across multiple analytical 
replicates, total replicate variance can be separated into 
systematic and nonsystematic components. This approach 
could allow a very significant correction in systematic error 
and a large reduction in analytical replicate variance and in 
propagated error in downstream analyses. 
Example 2. Develop basic biostatistical analysis of 
refined data. The present inventors are developing basic 
biostatistical analyses and visualizations of SIRM datasets 
that: i) support the optimal design of SIRM-based experi-
ments with sufficient statistical power and ii) promote sound 
metabolic interpretation of SIRM data. Specifically, statis-
tical power estimation tools for common SIRM experimen-
tal designs are contemplated, especially matched case-con-
trol paired experimental designs, which have better 
statistical power. More advanced statistical and machine 
learning methods will also be used to assess sample dis-
crimination and classify samples with respect to biological 
states and conditions of interest. 
Correlated metabolite clique analysis. Again using opti-
mal "maximal clique" identification methods [37, 38], the 
present inventors will identify positively correlated sets of 
isotopologues and isotopomers and metabolite-specific 
chemical moieties representing relative flux. The focus on 
correlated metabolite cliques is pragmatic for maintaining a 
low false discovery rate (FDR) [39, 40] and preventing type 
I errors, which is achieved by using the correlated cliques to 
estimate covariance, effectively reducing the dimensionality 
16 
standard error, range, 95% CI, t-test in its various variants, 
ANOVA, general linear regression, logistic regression, and 
statistical power calculations. To identify significant differ-
ences, the ratio (using threshold ratio) of the control and 
5 perturbed groups will be compared using Fisher's Exact test 
[43] and then logistic regression will be used to model and 
test the effect of other covariates such as age and gender. 
Metabolites will also be compared using GLM procedures, 
including covariates such as age, gender, polyploidy where 
10 relevant. Correlation clustering methods are particularly 
good at handling high dimensional datasets [ 44]. 
A variety of tools available in Python and Rand elsewhere 
are used to visualize datasets in a variety of ways. Principal 
Components Analysis (PCA) is used to visualize informa-
15 tion content and its dimensionality with respect to variance. 
Partial least square discriminant analysis (PLS-DA) and 
newer OPLS-DA methods [45] will be used to assess class 
separability of samples, even if implementation of a version 
of OPLS-DA is required ( currently no released R or Python 
20 package appears available). 3D data displays and heat maps 
will be used to visualize correlations among detected isoto-
pologues and categories of samples as derived from various 
clustering methods. The new R-based tool NeatMap that 
generates heat maps from non-clustering methods like PCA 
25 [46] will be used, allowing side-by-side comparison with 
results from clustering methods. Open source tools like 
Cytoscape [32, 33] will be used for network visualization. 
Construction of classification models. Using both refined 
metabolite data and accepted metabolite cliques, prediction 
30 and classification models will be built and evaluated using a 
variety of model building methods. Following a visual 
review of the data with PLS-DA and OPLS-DA [47, 48], 
machine learning methods will be used, including random 
forest [49, 50] and support vector machines with kernel 
35 selection [51, 52]. These machine learning methods are 
better at dealing with nonlinear correlations that may be 
present in a dataset. Moreover, random forest excels at 
multi-category classification. Various PLS-based, kernel-
based OPLS [53], and machine learning methods are imple-
40 mented as packages in R. of the datasets. This is especially important for subsequent 
analyses that deal with sample classification and mecha-
nism-based hypothesis generation. When matched case-
control datasets are being analyzed, the correlation will be 
calculated using the difference in the normalized isotopo-
logue intensity or chemical moiety parameter value. The 
covariance error matrix will be calculated from a set of 
analytical replicates and this matrix will be used as a 
weighting factor to compensate for the non-independent 
error expected with these highly correlated datasets [41]. 
The significance and statistical power of correlated metabo- 50 
lite cliques will be evaluated with respect to intra-clique-
correlation, correlation to specific metabolic pathways, and 
effect sizes (for matched case-control datasets). Criteria will 
Example 3. Develop metabolic network reconstruction, 
moiety deconvolution tools, and omics-level data integration 
for mechanism-based analysis of biological processes. The 
present inventors will build upon manual approaches that 
45 interpret SIRM data within the context of relevant metabolic 
networks and facilitate mechanism-based analysis of corre-
lated metabolites. Specifically, tools are being developed 
that will automate reconstruction of metabolic networks that 
are relevant for the interpretation of SIRM time-series 
experiments and SIRM datasets will be deconvoluted to 
determine relative pathway fluxes through these networks. 
The resulting pathway-specific information will serve as a 
point of integration and cross-validation with genomics, 
transcriptomics, and proteomics data, enabling interpreta-
tion of metabolic phenotypes within the context of specific 
metabolic and signaling pathways that are part of biological 
be used based on a combination of these measures along 
with a minimum clique-size to limit which cliques are 55 
accepted as meaningful metabolic phenotypes and used to 
build classification models. The criteria needed for a desired 
false discovery rate (FDR) will be empirically estimated via 
a series of simulations where a large number of random 
datasets are created and analyzed using expected correla- 60 
tions from known metabolic pathways, the levels of variance 
in experimental datasets, and the size of experimental data-
sets. This approach has been found to be valuable for 
significance testing in identifying relevant GO terms [42]. 
General statistical analysis and visualization. Packages in 65 
the R statistical programming language are currently used 
for common statistical analyses such as mean, median, 
processes of interest. This context-specific interpretation 
will generate mechanism-based hypotheses and additional 
tools for their testing. 
The present inventors are developing a combination of 
methods that will: i) analyze the relative isotope incorpora-
tion and perturbation of correlated metabolites of interest 
derived from raw data analyses and biostatistical analyses 
described above with respect to specific pathways within 
metabolic networks; ii) integrate this pathway-specific 
metabolomics information with genomics, transcriptomics, 
and/or proteomics data; and iii) facilitate relative flux inter-
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metabolic flux problem that can be accurately addressed by 
a isotopic non-steady-state full metabolic flux analysis [57-
59]. 
Integration and refinement of metabolic information. For 
pretation and full metabolic flux analysis of moiety decon-
voluted data within the context of specific metabolic and 
signaling pathways within biological processes of interest. 
The heart of these new methods are the moiety modeling 
methodologies and tools [1, 10] designed to deconvolute 
SIRM datasets. Non-steady-state experimental conditions 
are an unavoidable reality for most eukaryotic SIRM data-
sets, since true isotopic steady state is difficult or impractical 
5 
the tracer-based data analysis needs, web-based tools are 
being developed that: i) access relevant metabolite, meta-
bolic pathway, atom-resolved mappings, subcellular local-
ization, and tissue-specific gene expression information 
from public databases and ii) combine and refine this 
information for mapping to relevant parts of the targeted to achieve, especially in animal systems. The moiety mod-
eling methods are designed to handle the specific informa-
tion-rich, isotopic non-steady-state conditions of these 
experiments. From these analyses, the present inventors can 
derive pathway-specific relative flux and perturbation detail-
ing the functional significance of particular metabolic phe-
15 
notypes of interest. Application of these methodologies 
entails the following: 
10 metabolic network. These web-based tools will extract 
Integration and refinement of organism-specific metabolic 
information. 
metabolic pathway information from a variety of sources 
including: KEGG Ligand for atom-resolved metabolic path-
ways for over a thousand organisms [26]; ARM for the most 
complete atom-resolved metabolic pathways in E. coli [ 60]; 
MetaCyc family of databases for the most complete meta-
bolic maps [ 61, 62]; and Reactome for human subcellularly-
localized metabolic pathways [63, 64]. With the use of the 
Django web framework, a database schema for an enhanced 
atom-resolved metabolic network based on KEGG Ligand Moiety model creation. 
1. Moiety model optimization and selection. 
2. Quantitative pathway analysis and relative pathway 
flux interpretation. 
3. Integration with genomics, transcriptomics, and/or pro-
teomics data. 
20 has been implemented and is now being testing via scraping, 
processing, and populating with data from KEGG Ligand. 
This implementation allows easy portability to several dif-
ferent physical databases including MySQL, PostgreSQL, 
The approach is to extract the necessary parts of meta- 25 
bolic networks according to given tracer inputs. For any set 
of input tracers, first their transformation pathways are 
selected and defined as the initial network. The fates of 
individual atoms are traced through the initial network and 
major downstream pathways are included stepwise. This 30 
process is performed iteratively so that the network size is 
kept within a computationally feasible scale. Here, the 
approach with a combined NMR and FT-ICR-MS SIRM-
based study on the biosynthesis of UDP-GlcNAc is illus-
trated[!] (cf. FIG. 12), which is a key donor for N- and 
0-linked protein glycosylation [54-56]. UDP-GlcNAc has a 35 
unique NMR spectrum that is resolved from UDP-GalNAc 
and other UDP sugars. Based on the individual components 
of UDP-GlcNAc (FIG. 13b) and their known biosynthetic 
pathways (FIG. 12), a chemical substructure model (FIG. 
13a) was constructed to enable non-steady state modeling of 40 
13C incorporation from labeled glucose into UDP-GlcNAc. 
The possible 13C labeled isotopologues (cf. FIG. 13a) 
deduced from the pathways and FT-ICR-MS data were then 
used as model parameters in a combined simulated anneal-
ing/genetics optimization algorithm implemented in the pro-
45 
gram GAIMS [1]. Fitting these model parameters to the 18 
observed FT-ICR-MS 13C-only isotopologue series (mO to 
mO+l 7, FIG. 13c), while accounting for the 13C natural 
abundance, defined relative flux through multiple connect-
ing pathways between glucose and UDP-GlcNAc (FIG. 14), 
without the prerequisite for isotopic steady-state [1 OJ. More- 50 
over, the relevant network reconstruction, moiety deconvo-
lution, and moiety model selection simplifies and frames the 
and SQLite, which have been directly tested during the 
evolution of this database schema. 
However, the real problems are in obtaining useful and 
reliable subcellular localization annotation. Currently, the 
metabolic pathway databases link back to Uniprot [65, 66] 
which aggregates annotation at the "protein" record. Table 2 
represents a preliminary analysis of the Swiss-Prat version 
(downloaded Mar. 5, 2012) of Uniprot showing human 
enzymes organized by major EC number group versus 
subcellular localization. However, many genes are tran-
scribed into multiple RNA transcripts which encode differ-
ent isoforms of a protein. Uniprot stores only one composite 
"protein" record for almost all isoforms of a particular 
protein gene product. All the annotations for each isoform 
are simply aggregated under the single "protein" record with 
the relationship between isoform and annotation lost. This is 
a problem since the most reliable annotations are in the 
manually curated and reviewed Swiss-Prat. Now EMBL-
ENA [67-69] has annotations associated at the RNA tran-
script level; however EMBL-ENA includes less reliable 
automatic annotations. In fact, the EMBL-ENA is translated 
into the TrEMBL version of Uniprot which also has anno-
tations aggregated in the "protein" record. Since TrEMBL 
has Swiss-Prat annotations removed to prevent duplication 
of annotation, the present inventors will filter EMBL-ENA 
against Swiss-Prat in order to produce a dataset of reliable 
subcellular localization annotations associated directly with 
its RNA transcript. This will be invaluable for later integra-
tion with transcriptomics and proteomics datasets. 
TABLE 2 
Human enzymes organized by major EC# group & subcellular 
localization annotation from Swiss-Prot. 
Cytoplasmic Endoplasmic 
EC awosouelauti Golgi Lysosome Cytoplasm Secreted Cell Membrane Vesicle Nucleus Reticulum Peroxisome Mitochondrion 
3 7 6 113 37 49 57 116 27 118 
2 195 7 473 37 292 20 360 137 10 130 
3 9 51 68 414 244 308 19 378 89 9 82 
4 0 2 0 29 2 22 12 7 6 16 
5 0 3 0 31 3 8 0 21 19 6 12 
6 6 9 9 153 41 10 90 27 7 58 
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Protein-protein interactions are another important type of 
annotation in metabolic networks and especially useful in 
deducing nonsymmetric catalysis of symmetric molecules, 
which is common in multienzyme complexes. However, 
protein-protein interactions are not nearly as conserved as 
enzymatic function and are much harder to predict. Poten-
tially useful protein-protein interaction databases like iPfam, 
PIBASE, DOMMINO, and MIPS [70-73] and various pre-
diction methods are being investigated [74-79]. Also, new 
semantic relationships added to Gene Ontology [80] will aid 
in combining localization with cellular component annota-
tions [81]. 
Develop atom-resolved pathway tracing and metabolic 
network reconstruction methods for moiety model creation. 
The present inventors are drawing on classic graph theory as 
a starting point for developing algorithms that trace relevant 
short paths through metabolic networks from labeled tracers 
to enriched metabolite isotopologues and isotopomers. Both 
k-shortest paths [82] and k-shortest simple paths (loopless) 
[83] algorithms will be employed to trace isotope from the 
labeling source to every labelable atom in the assigned 
metabolite. Preference is given to paths that combine the 
largest co-tracing of atoms, which represent the flow of 
specific functional moieties through the metabolic network. 
Since the metabolomic database in KEGG for any given 
organism is incomplete, tracings will be used from other 
organisms (1000 in KEGG) as hypothetical pathways. The 
metabolites and labeling patterns assigned from FT-MS and 
NMR time series data will be used to verify or refute all 
plausible hypothetical pathways. Finally, detected unidenti-
fied metabolites will be placed within the reconstructed 
metabolic networks based on: their molecular formulae/ 
functional groups (from FT-ICR-MS), identified substruc-
ture (NMR), time series correlations with known metabo-
lites, and labeling patterns. 
With the metabolic information described above aggre-
gated into an atom-resolved metabolic network specific to 
the organism of interest, the methods being developed will 
be able to trace groups of atoms or chemical moieties from 
a labeled source molecule to an observed metabolite through 
numerous metabolic transformations in cellular metabolism 
of the appropriate organism. As with any complex network, 
many different tracings are possible. Currently, models are 
described manually using a moiety model description lan-
guage [1]. Web-based tools are being developed to aid in 
creating moiety models. These tools will also help generate 
related sets of plausible moiety models from relevant meta-
bolic pathway information. Model creation requires four 
separate steps: i) search for relevant plausible metabolic 
pathways as described above; ii) identify traceable chemical 
moieties; iii) identify chemical moiety labeling states (i.e. 
possible levels of stable isotope labeling in the moiety); and 
iv) generate model description. Each step will be linked by 
common file formats and data structures, like the chemical 
moiety model description language (CMMDL), composed 
of nested name-value pairs describing traceable chemical 
moieties and their possible labeling states. The CMMDL 
parser will be expanded to simultaneously handle multiple 
metabolites with cross-dependencies between moiety sub-
structures as the moiety model creation tools are developed 
into fully automated versions. These improvements will 
eventually allow simultaneous analysis of hundreds or even 
thousands of metabolites. 
Moiety model optimization and selection. A parameter 
optimization tool has been developed that uses a simulated 
annealing genetic algorithm to optimize chemical moiety 
state parameters based on experimental data for a given 
20 
chemical moiety model description [1]. A specific applica-
tion of this tool is illustrated in FIG. 13. Since optimizations 
are normally repeated many times, this tool can be run on a 
Linux cluster in a distributed fashion via the use of stan-
5 dardized queue submission protocols (openPBS/TORQUE). 
These facilities will be expanded to handle the parameter 
optimization of models involving multiple metabolites. Fur-
thermore, hierarchical and jack-knife approaches will be 
developed when optimizing moiety state parameters of 
10 many metabolites. Both approaches begin with the param-
eter optimization of individual and small correlated sets of 
metabolites (correlated metabolic cliques) before optimiza-
tion across larger sets of parameters. These approaches are 
needed to efficiently optimize parameters for thousands of 
15 metabolites simultaneously. 
A robust model selection method has also been imple-
mented using the Akaike information criterion (AIC) [84] 
applied to average optimized parameter values [1]. Highly 
plausible models and often a unique model are selected from 
20 a large possible set using the SIRM time-course data. This 
allows the SIRM experimental data to test hypotheses of 
metabolic pathways made during moiety model creation, 
filling in gaps in current organism-specific metabolic infor-
mation. Although the preliminary results with this model 
25 selection method applied to single metabolite models indi-
cate a very robust selection method, harder problems could 
arise when selecting models involving multiple metabolites. 
Anticipating cases where multiple models are selected, 
additional model comparison tools will be developed that 
30 will identify common components between chemical moiety 
models, which will demonstrate high confidence in these 
components. Furthermore, it will be necessary to apply 
model selection earlier in the model creation and optimiza-
tion steps to prevent a combinatorial explosion in the 
35 number of multiple metabolite models that need to be tested. 
Very low probability branches in the model search tree can 
be trimmed to limit this combinatorial explosion. Moreover, 
submode! selection and submode! likelihood functions may 
be required to direct model creation when all possible 
40 models cannot be enumerated. 
Quantitative pathway analysis and flux modeling. Deter-
mining the time evolution of moiety state parameters pro-
vides the means to determining pathway fluxes. From this 
analysis, the present inventors know the relative substruc-
45 ture fluxes from the labeling source to the metabolite 
through atom-resolved metabolic pathways identified from 
model selection. By comparing these multiple pathways 
from labeled source to detected metabolites the following 
can be identified: i) localized pathways in common; ii) 
50 branch points in these pathways, which often represent sites 
of regulation; and iii) the relative fluxes through these 
branches. Changes in these relative fluxes would indicate a 
change in the regulation at these branch points and provide 
significant mechanistic understanding for representative 
55 metabolic phenotypes. 
Facilitating 'omics' integration and mechanism-based 
hypothesis generation. Perturbed pathways derived from 
correlated metabolite cliques and changes in relative flux 
will become a common point of integration and cross-
60 validation with other omics-level coupled datasets that are 
obtained. As an analytical cross-validation with metabolo-
mics, this approach is statistically more powerful than 
pathway enrichment analysis strategies [85, 86]. Specific 
protein gene products identified by this cross-validation with 
65 omics-level datasets under perturbed conditions become 
potential hypotheses for the perturbation mechanism. To 
complement this coupled-experiment approach, relevant 
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omics-level datasets already in the public repositories like 
genetic variations in dbSNP [87], transcriptomics data in 
GEO [88, 89], and proteomics data in PRIDE [90, 91] will 
be analyzed. GEO search methods and dbSNP search meth-
ods are being explored. 
Alternative Approaches. One problem already mentioned 
22 
Component 1. Mathematical Formulas Implemented in 
Algorithms that Calculate Natural Abundance Probabilities 
for Isotopes of Non-labeling Elements. 
n 
NAP= n PEJ 
j=l 
The above equations describe the calculation of the natu-
ral abundance probability (NAP) for specific isotopically-
resolved molecular formulas. In the case where a specific 
isotope(s) comes from a labeling source, a relative NAP is 
calculated where that isotope's contribution to the element's 
probability (PE) is omitted. For isotope combinations for 
elements containing 3 or more isotopes, one of which is 
is the incomplete information on metabolic networks of 
various organisms and their compartmentation. Tools will be 
developed that can generate more complete metabolic path-
ways from other organisms and validate these hypothetical 10 
pathways using SIRM experimental data. Another known 
problem is that not all metabolites are in the databases. The 
combined molecular formula, functional group, and sub-
structure information will be used to search ChemSpider 
(http://www.chemspider.com/) for candidate structures. Fur- 15 
ther analysis of NMR data and MS/MS fragmentation pat-
terns can be used to refine this list of candidates. Another 
potential issue is the combinatorial explosion in chemical 
moiety model creation and optimization involving large 
numbers of metabolites. This can be addressed using a 
combination of approaches: i) use submode! optimization 
and selection to eliminate highly improbable models; ii) use 
metabolic clique analysis, hierarchical, and jack-knife 
approaches to direct model optimization and selection; and 
iii) distribute the parameter optimization across a large 
computer cluster ( e.g. University of Louisville CRC). 
Another potential issue is building good classification mod-
els. A variety of statistical and machine learning methods 
can be used to find the best classifier and identify key 
metabolic cliques. To handle non-independent error in the 30 
datasets and the covariance in time series, a set of analytical 
replicates will be used to calculate an error covariance 
matrix. A GEE model will be used to deal with issues of 
covariance in the time series [92] [93]. 
20 labeled, a relative NAP can be calculated using the remain-
ing isotopes else the relative NAP is set to one. 
Component 2. Large Sorted Caches of Molecular Formula 
Fragments for a Subset of Isotopes being Searched. 
The problem of searching for probable isotopically-re-
25 solved molecular formulas is a huge combinatorial problem 
that becomes intractable on even large supercomputers for 
molecular masses over 500 Daltons. In order to make this 
problem tractable, one must build a large sorted cache of 
plausible molecular formula fragments using the NAP from 
Component 1 and metabolite bonding pattern rules for the 
elements in the cache. The cache reduces the molecular 
formula search time by a ratio of the time to build the cache 
(typically >10,000 CPU hours) versus the time it takes to 
search the cache (i.e. milliseconds or better). An example 
Example 4. Metabolite Identification in Ultra-high Reso-
lution Mass Spectrometry. The present inventors have devel-
oped and prototyped a system and method that determines 
the isotope-resolved molecular formula for metabolites 
detected via sets of related isotopologues from mass spectra 
35 metabolite bonding pattern rule is the number of hydrogen 
atoms in a molecular formula is bounded by the number of 
carbon and nitrogen atoms in the molecular formula. 
Component 3. Peak Characterization and Detection of 
Artefactual Peaks 
of samples that have been labeled with specific stable 40 
isotopes like 13C, 15N, and 2H from a given labeling source 
and/or from natural abundance. 
Detected peaks within spectra collected from Fourier 
transform mass spectrometers have a variety of data quality 
issues including m/z peak shifting (FIG. 2), inconsistency in 
peak heights and areas (FIG. 3), and the presence of arte-
factual peaks. These data quality issues arise from: i) limi-
The approach requires multiple components to overcome 
the inherent combinatorial problem related to finding the 




16O6 versus C6H12O6) out of roughly 1.1 qua-
drillion (1.lxl015) of possible combinations that must be 
searched for each isotopologue with a molecular mass of 
less than 2000 Daltons. The components include: i) math-
ematical formulas implemented in algorithms that calculate 
natural abundance probabilities for isotopes of non-labeling 
elements; ii) large sorted caches of molecular formula frag-
ments for a subset of isotopes being searched; iii) algorithms 
that characterize peaks from raw a raw spectrum and sepa-
rate sample-specific peaks from various spectral artefacts 
seen in ultra-high resolution Fourier transform mass spectra; 
iv) algorithms that create sets of possible isotopically-
resolved molecular formulas by iteratively searching the 
molecular formula caches, combining with additional iso-
topes and molecular fragments, and statistically filtering 
resulting isotopically-resolved molecular formulas; v) algo-
rithms that identify metabolite cliques and super-cliques of 
isotopologues via the comparison of sets of possible isoto-
pically-resolved molecular formulas from different isotopo-
logues that identify compatible element-resolved molecular 
formulas in a statistically robust manner. These components 
will now be discussed in more detail. 
45 tations in digital resolution (FIG. 4); ii) problems with 
scan-level consistency (FIG. 5); and iii) Fourier transform-
based artefacts (FIG. 6), and iv) the presence of contami-
nants. However, standard peak picking methods that average 
across scans create huge data quality issues. Therefore, an 
50 integrated procedure using a combination of new scan-level 
peak characterization methods along with artefact peak 
detection methods are required to derive high quality peak 
characteristics associated with specific isotopologues. Peak 
characterization at the scan-level is implemented by remov-
55 ing noise peaks per scan, corresponding peaks across scans, 
and performing normalization of peak heights/areas across 
scans. The resulting correspondence peaks are used to derive 
high quality peak heights and areas (FIGS. 7 and 8) while 
removing many of the high peak density artefacts present 
60 but inconsistent at the scan-level. Separate high peak density 
analyses and contaminant detection will remove or mark the 
remaining artefactual peaks. A set of contaminant molecules 
can be based on expected contaminate molecules from the 
plastics and solvents used in sample preparation including 
65 polymers like polyethylene glycol (PEG) and polymer deter-
gents like triton X-100 or derived from quality control 
samples directly. A difference matrix generated from this list 
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tification of both cliques and super-cliques of isotopologue 
peaks associated with a specific metabolite or a set of 
metabolite isomers. Also, this approach is applicable to a 
directed search of known elemental molecular formulas by 
of expected molecules is compared to the difference matrix 
generated from the peak list derived from a mass spectrum. 
Rows between the two matrices with a statistically signifi-
cant number of differences that match are used to assign 
expected contaminant peaks and derive offsets present in the 
spectrum. 
5 building an isotopically-resolved cache (Component 2) for 
these known elemental molecular formulas. And this 
Component 4. Algorithms that Create Sets of Possible 
Isotopically-resolved Molecular Formulas by Iteratively 
Searching the Molecular Formula Caches, Combining with 
Additional Isotopes and Molecular Fragments, and Statisti- 10 
cally Filtering Resulting Isotopically-resolved Molecular 
Formulas. 
Each isotopologue is identified by a peak with a specific 
mass to charge ratio (m/z ratio) position in the ID mass 
spectrum. The peak also has an intensity related to the 15 
number of ions physically detected in the mass spectrometer. 
For each isotopologue, a set of possible isotopically-re-
solved molecular formulas are calculated within a specified 
accuracy tolerance using Component 2 to build specific 
isotopically-resolved molecular formulas and that are then 20 
filtered against the NAP from Component 1, a statistical 
measure of how well the molecular formula matches the m/z 
ratio (m/z matching probability), and metabolite bonding 
pattern rules. 
Component Sa. Algorithms that Identify Metabolite 25 
Cliques of Isotopologues Via the Comparison of Sets of 
Possible Isotopically-resolved Molecular Formulas from 
Different Isotopologues that Identify Compatible Element-
resolved Molecular Formulas in a Statistically Robust Man-
ner. 30 
A pair of isotopologues are compared via an intersection 
between their sets of isotopically-resolved molecular for-
mulas that identify compatible isotopically-resolved 
molecular formulas. Each intersecting pair of complemen-
tary isotopiocally-resolved molecular formulas that corre- 35 
spond to the same elemental molecular formula and has 
equal numbers oflabeling isotopes are statistically evaluated 
using both m/z matching-probabilities from Component 4 
and a log ratio of isotopologue peak intensities statistically 
compared to the log ratio of each isotopically-resolved 40 
molecular formula NAP from Component 1 (log-ratio match 
probability). Each compatible intersecting pair of isotopi-
cally-resolved molecular formulas represent evidence for 
specific elemental molecular formulas (i.e. metabolites) in 
the mass spectrum. Specific elemental molecular formulas 45 
are identified by statically evaluating the sum of compatible 
intersecting pairs of isotopically-resolved molecular formu-
las that support the same elemental molecular formula. The 
resulting analysis identifies a clique of isotopologue peaks 
associated with a specific elemental molecular formula (i.e. 50 
a metabolite isotopologue-offset clique). 
Component 5b. Algorithms that Identify Super-cliques of 
Related Element-resolved Cliques of Isotopologues in a 
Statistically Robust Manner. 
A pair of detected metabolite isotopologue-offset cliques 55 
from Component Sa are statistically compared using the 
matrix of log intensity ratios from Component 5b to identify 
super-cliques within a mass spectrum with inter-clique dif-
ferences in both elemental and isotope-specific molecular 
formulae. These differences reflect additions of known che- 60 
moselective tags and/or adducts to specific metabolites 
represented by the elemental molecular formula of the base 
clique. 
approach is applicable to the analysis of tandem mass 
spectroscopic (MSn) data, where the set of possible isoto-
pically-resolved molecular formulas of specific fragment 
isotopologues are statistically intersected with the set of 
possible isotopically-resolved molecular formulas of the 
parent isotopologue. 
Included with this disclosure is an Appendix which 
includes previous U.S. Provisional Patent Application Ser. 
No. 62/187,901. 
All publications, patents, and patent applications men-
tioned in this specification are herein incorporated by ref-
erence to the same extent as if each individual publication, 
patent, or patent application was specifically and individu-
ally indicated to be incorporated by reference. 
It will be understood that various details of the presently 
disclosed subject matter can be changed without departing 
from the scope of the subject matter disclosed herein. 
Furthermore, the foregoing description is for the purpose of 
illustration only, and not for the purpose of limitation. 
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What is claimed is: 
1. A method for mass spectrometry data analysis for 
identification of a specific elemental molecular formula 
(EMF) for an unknown compound, the method comprising: 
calculating a natural abundance probability (NAP) of a 
given isotopologue for isotopes of a predetermined 
mass and elemental boundary for non-labeling ele-
ments of an unknown compound based on chemical 
norms for possible structures; 
creating caches of non-ionized molecular fragments for a 
subset of isotopes identified using the NAP values for 
isotopologues above a NAP cutoff which is based on an 
expected detection dynamic range for a specific mass 
spectrometry instrument; 
sorting the caches of molecular fragments into a requisite 
cache data structure, to be searched; 
characterizing peaks from a raw mass spectrum composed 
of multiple scans without spectral nor regional averag-
ing for an unknown compound and separating sample-
specific peaks from various spectral artefacts seen in 
ultra-high resolution Fourier transform mass spectra; 
creating sets of possible isotope-resolved molecular for-
mulae (IMF) by iteratively searching the molecular 
fragment caches and combining with additional iso-
topes and then statistically filtering the results based on 
NAP and mass-to-charge (m/z) matching probabilities; 
and 
identifying an unknown compound and its corresponding 
EMF from statistically-significant cliques of isotopo-
logues with compatible IMFs. 
2. The method of claim 1, wherein calculating a natural 
abundance probability (NAP) of a given isotopologue for 
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isotopes of non-labeling elements of an unknown compound 
comprises applying the equation: 
n 
NAP= n PEJ 
j=l 
where, in an instance a specific isotope(s) comes from a 
labeling source, probability (PE) is omitted from the 
calculation. 
10 
3. The method of claim 1, wherein creating caches of 15 
non-ionized molecular fragments for a subset of isotopes 
identified using the NAP, and sorting the caches of molecu-
lar fragments into the requisite cache data structure, com-
prises: 
enumerating molecular fragments for a given set of iso- 20 
tapes within a mass specified mass range, 
36 
filtering the set of possible IMF(s) against: 
i) the NAP 
ii) a statistical measure of how well the molecular formula 
matches the m/z ratio (m/z matching probability), and 
iii) metabolite bonding pattern rules. 
7. The method of claim 1, wherein identifying a metabo-
lite and its corresponding EMF from statistically-significant 
cliques of isotopologues with compatible IMFs comprises: 
identifying a nonempty intersection between sets of pos-
sible EMFs identify from possible IMFs; 
statistically evaluating using both the m/z matching prob-
abilities calculated, for each complementary pair of 
isotopologues from one of the specific respective EMF 
cliques and statistically comparing a log ratio of iso-
topologue intensities to a log ratio of each of the IMF 
NAP, 
wherein the isotopologue intensities used in the ratios are 
derived from associated 
characterized peaks; and 
identifying specific EMF cliques identified by statically 
evaluating the sum of complementary pair probabili-
ties/likelihoods against a statistical alpha. calculating partial NAP for each molecular fragments, 
filtering molecular fragments based on a given NAP 
cutoff, 
sorting molecular fragments by mass, and 
generating a binary or b-tree searchable molecular frag-
ment cache. 
8. The method of claim 7, wherein complementary pair of 
isotopologues represents a statistically evaluated piece of 
25 evidence supporting the existence of the associate EMF 
clique in the mass spectrum. 
4. The method of claim 1, wherein characterizing peaks 
from the raw mass spectrum and separating sample-specific 
peaks from various spectral artefacts seen in ultra-high 30 
resolution Fourier transform mass spectra comprises: 
removing noise peaks from multiple mass spectrometry 
scans of the unknown compound, 
corresponding peaks across the multiple scans after noise 
peaks removed, and 
performing normalization of peak heights/areas across 
scans. 
35 
5. The method of claim 4, wherein identifying a metabo-
lite and its corresponding EMF from statistically-significant 
cliques of isotopologues with compatible IMFs comprises: 40 
identifying a nonempty intersection between sets of pos-
sible EMFs identify from possible IMFs; 
statistically evaluating using both the m/z matching prob-
abilities calculated, for each complementary pair of 
isotopologues from one of the specific respective EMF 45 
cliques and statistically comparing a log ratio of iso-
topologue intensities to a log ratio of each of the IMF 
NAP, 
wherein the isotopologue intensities used in the ratios are 
derived from associated 
characterized peaks; and 
identifying specific EMF cliques identified by statically 
evaluating the sum of complementary pair probabili-
ties/likelihoods. 
50 
6. The method of claim 1, wherein creating sets of 55 
possible isotope-resolved molecular formulae (IMF) by 
iteratively searching the molecular fragment caches and 
combining with additional isotopes and then statistically 
filtering the results based on NAP and mass-to-charge (m/z) 
matching probabilities comprises: 60 
identifying each isotopologue by a peak with a specific 
mass to charge ratio (m/z ratio) position in a ID mass 
spectrum; 
calculating, for each characterized isotopologue peak, 
within a specified accuracy tolerance, using the cache 65 
data structurem, a set of possible, isotopically-resolved 
molecular formulas (IMFs) to build the specific IMF(s ); 
9. The system of claim 1, wherein identifying a metabolite 
and its corresponding EMF from statistically-significant 
cliques of isotopologues with compatible IMFs comprises: 
identifying a nonempty intersection between sets of pos-
sible EMFs identify from possible IMFs; 
statistically evaluating using both the m/z matching prob-
abilities calculated, for each complementary pair of 
isotopologues from one of the specific respective EMF 
cliques and statistically comparing a log ratio of iso-
topologue intensities to a log ratio of each of the IMF 
NAP, 
wherein the isotopologue intensities used in the ratios are 
derived from associated 
characterized peaks; and 
identifying specific EMF cliques identified by statically 
evaluating the sum of complementary pair probabili-
ties/likelihoods. 
10. The method of claim 1, wherein the unknown com-
pound is a metabolite. 
11. A system of mass spectrometry data analysis for 
identification of a specific elemental molecular formula 
(EMF) for an unknown compound, the system comprising: 
computer memory adapted to store mass spectrometry 
data for an unknown compound; and 
a computer processor adapted for performing analytics on 
mass spectrometry data from mass spectrometry for the 
unknown compound, said processor: 
calculating a natural abundance probability (NAP) of a 
given isotopologue for isotopes of a predetermined 
mass and elemental boundary for non-labeling ele-
ments of an unknown compound based on chemical 
norms for possible structures; 
creating caches of non-ionized molecular fragments for a 
subset of isotopes identified using the NAP values for 
isotopologues above a NAP cutoff which is based on an 
expected detection dynamic range for a specific mass 
spectrometry instruction; 
sorting the caches of molecular fragments into a requisite 
cache data structure, to be searched; 
characterizing peaks from a raw mass spectrum composed 
of multiple scans without spectral nor regional averag-
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ing for an unknown compound and separating sample-
specific peaks from various spectral artefacts seen in 
ultra-high resolution Fourier transform mass spectra; 
creating sets of possible isotope-resolved molecular for-
mulae (IMF) by iteratively searching the molecular 5 
fragment caches and combining with additional iso-
topes and then statistically filtering the results based on 
NAP and mass-to-charge (m/z) matching probabilities; 
and 
38 
14. The system of claim 11, wherein characterizing peaks 
from the raw mass spectrum and separating sample-specific 
peaks from various spectral artefacts seen in ultra-high 
resolution Fourier transform mass spectra comprises: 
removing noise peaks from multiple mass scans of the 
unknown compound, 
corresponding peaks across the multiple scans after noise 
peaks removed, and 
performing normalization of peak heights/areas across 
scans. 
identifying an unknown compound and its corresponding 
EMF from statistically-significant cliques of isotopo- 10 
!agues with compatible IMFs. 
15. The system of claim 11, wherein creating sets of 
possible isotope-resolved molecular formulae (IMF) by 
iteratively searching the molecular fragment caches and 
15 combining with additional isotopes and then statistically 
filtering the results based on NAP and mass-to-charge (m/z) 
matching probabilities comprises: 
12. The system of claim 1, wherein calculating a natural 
abundance probability (NAP) of a given isotopologue for 
isotopes of non-labeling elements of an unknown compound 
comprises applying the equation: 
n 
NAP= n PEJ 
j=l 
20 
where, in an instance a specific isotope(s) comes from a 
25 
labeling source, probability (PE) is omitted from the 
calculation. 
13. The system of claim 11, wherein creating caches of 
non-ionized molecular fragments for a subset of isotopes 
identified using the NAP, and sorting the caches of molecu-
lar fragments into the requisite cache data structure, com- 30 
prises 
enumerating molecular fragments for a given set of iso-
topes within a mass specified mass range, 
calculating partial NAP for each molecular fragments, 
filtering molecular fragments based on a given NAP 35 
cutoff, 
sorting molecular fragments by mass, and 
generating a binary or b-tree searchable molecular frag-
ment cache. 
identifying each isotopologue by a peak with a specific 
mass to charge ratio (m/z ratio) position in a ID mass 
spectrum; 
calculating, for each characterized isotopologue peak, 
within a specified accuracy tolerance, using the cache 
data structurem, a set of possible isotopically-resolved 
molecular formulas (IMFs) to build the specific IMF( s ); 
filtering the set of possible IMF(s) against: 
i) the NAP 
ii) a statistical measure of how well the molecular formula 
matches the m/z ratio (m/z matching probability), and 
iii) metabolite bonding pattern rules. 
16. The system of claim 11, wherein the caches of 
molecular fragments are stored in the computer memory 
and/or secondary storage, and said caches in the computer 
memory and/or the secondary storage are in an order up to 
multiterabytes in size. 
17. The system of claim 11, wherein the unknown com-
pound is a metabolite. 
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